These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Gene therapy progress and prospects cancer: oncolytic viruses. Liu TC; Kirn D Gene Ther; 2008 Jun; 15(12):877-84. PubMed ID: 18418413 [TBL] [Abstract][Full Text] [Related]
5. Optimization and preclinical design of genetically engineered viruses for human oncolytic therapy. Hiss DC; Fielding BC Expert Opin Biol Ther; 2012 Nov; 12(11):1427-47. PubMed ID: 22788715 [TBL] [Abstract][Full Text] [Related]
6. Chapter four--Design of improved oncolytic adenoviruses. Alemany R Adv Cancer Res; 2012; 115():93-114. PubMed ID: 23021243 [TBL] [Abstract][Full Text] [Related]
7. Oncolytic virus therapy using genetically engineered herpes simplex viruses. Todo T Front Biosci; 2008 Jan; 13():2060-4. PubMed ID: 17981691 [TBL] [Abstract][Full Text] [Related]
8. Modification of oncolytic adenovirus and its application in cancer therapy. Liang Y; He J; Zhao Y Discov Med; 2020; 30(161):129-144. PubMed ID: 33593481 [TBL] [Abstract][Full Text] [Related]
9. The promise of microbial engineering for developing new strategies for tackling human disease. López-Goñi I Future Microbiol; 2012 Feb; 7(2):167-9. PubMed ID: 22324983 [No Abstract] [Full Text] [Related]
16. Potentiation of oncolytic virotherapy with armed shRNA. Guo W; Fang B Cancer Biol Ther; 2009 Jan; 8(1):92-3. PubMed ID: 19127117 [No Abstract] [Full Text] [Related]
17. Development of Group B Coxsackievirus as an Oncolytic Virus: Opportunities and Challenges. Liu H; Luo H Viruses; 2021 Jun; 13(6):. PubMed ID: 34198859 [TBL] [Abstract][Full Text] [Related]
18. Integrating oncolytic viruses in combination cancer immunotherapy. Bommareddy PK; Shettigar M; Kaufman HL Nat Rev Immunol; 2018 Aug; 18(8):498-513. PubMed ID: 29743717 [TBL] [Abstract][Full Text] [Related]